Current Marijuana Users Had 16% Lower Fasting Insulin and Smaller Waist Circumferences
In a nationally representative sample of 4,657 adults, current marijuana users had 16% lower fasting insulin levels, 17% lower insulin resistance scores, and smaller waist circumferences compared to non-users.
Quick Facts
What This Study Found
Using NHANES data from 2005-2010, researchers compared metabolic markers between 579 current marijuana users, 1,975 past users, and never-users. After adjusting for age, sex, race, alcohol use, tobacco use, income, physical activity, and BMI, current marijuana use was associated with 16% lower fasting insulin (95% CI: -26% to -6%) and 17% lower HOMA-IR (95% CI: -27% to -6%), an established measure of insulin resistance.
Current users also had significantly smaller waist circumferences. Past users showed intermediate values between current and never-users. No significant dose-response relationship was found among current users.
Key Numbers
4,657 adults. 579 current users, 1,975 past users. Current use: -16% fasting insulin (CI: -26, -6). -17% HOMA-IR (CI: -27, -6). Smaller waist circumference (significant). No dose-response among current users.
How They Did This
Cross-sectional analysis of NHANES 2005-2010 data. 4,657 adults. Self-reported marijuana use in a private room. Fasting blood samples after 9-hour fast. Multiple linear regression adjusting for demographics, lifestyle factors, and BMI.
Why This Research Matters
Lower insulin resistance is associated with lower risk of diabetes, cardiovascular disease, and metabolic syndrome. If the association with cannabis is causal, it could explain the epidemiological observation of lower diabetes prevalence among cannabis users and have implications for metabolic disease treatment.
The Bigger Picture
This is one of the strongest population-level studies linking cannabis use to favorable metabolic markers. The results are consistent with the endocannabinoid system's known role in metabolism and the finding of lower diabetes rates among cannabis users in other epidemiological studies.
What This Study Doesn't Tell Us
Cross-sectional design cannot establish causation. Cannabis users may differ from non-users in unmeasured ways (diet, lifestyle) that affect insulin. Self-reported cannabis use may be inaccurate. The lack of dose-response is difficult to explain if the effect is real. Adjustment for BMI may be over-adjustment if cannabis affects BMI.
Questions This Raises
- ?Is the insulin-lowering effect caused by cannabis or by characteristics of people who choose to use cannabis?
- ?Would a clinical trial of cannabinoids in pre-diabetic patients show insulin improvement?
- ?Does the type or method of cannabis consumption matter?
Trust & Context
- Key Stat:
- 16% lower fasting insulin and 17% lower insulin resistance in current marijuana users
- Evidence Grade:
- Large nationally representative sample with appropriate adjustments; moderate evidence for metabolic association.
- Study Age:
- Published in 2013. This study generated significant interest and further research into cannabinoids and metabolic health.
- Original Title:
- The impact of marijuana use on glucose, insulin, and insulin resistance among US adults.
- Published In:
- The American journal of medicine, 126(7), 583-9 (2013)
- Authors:
- Penner, Elizabeth A, Buettner, Hannah, Mittleman, Murray A(2)
- Database ID:
- RTHC-00716
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Does marijuana lower the risk of diabetes?
This study found that current marijuana users had lower insulin levels and less insulin resistance, both of which are associated with lower diabetes risk. However, this is an observational association that cannot prove cannabis prevents diabetes. People who use cannabis may be healthier in other ways that were not measured. Clinical trials would be needed to determine if cannabis actually improves metabolic health.
How could marijuana affect insulin?
The endocannabinoid system plays a well-established role in metabolism, appetite, and energy balance. Cannabis may modulate this system in ways that improve insulin sensitivity. Alternatively, the anti-inflammatory effects of cannabinoids could reduce the chronic inflammation that contributes to insulin resistance. The exact mechanism remains unknown.
Read More on RethinkTHC
- cannabis-cardiovascular-heart-risk-stroke
- cannabis-heart-cardiovascular-risk
- coughing-up-stuff-after-quitting-weed
- lung-recovery-after-quitting-smoking-weed
- lung-recovery-quitting-weed
- quitting-weed-female-hormones
- quitting-weed-weight-gain-loss-diet-appetite
- sex-after-quitting-weed
- weed-DUI-driving-impaired-cannabis-laws
- weed-acne-skin
- weed-fertility-sperm
- weed-gut-digestion-problems
- weed-heart-health
- weed-testosterone-levels
- why-does-weed-make-food-taste-better
Cite This Study
https://rethinkthc.com/research/RTHC-00716APA
Penner, Elizabeth A; Buettner, Hannah; Mittleman, Murray A. (2013). The impact of marijuana use on glucose, insulin, and insulin resistance among US adults.. The American journal of medicine, 126(7), 583-9. https://doi.org/10.1016/j.amjmed.2013.03.002
MLA
Penner, Elizabeth A, et al. "The impact of marijuana use on glucose, insulin, and insulin resistance among US adults.." The American journal of medicine, 2013. https://doi.org/10.1016/j.amjmed.2013.03.002
RethinkTHC
RethinkTHC Research Database. "The impact of marijuana use on glucose, insulin, and insulin..." RTHC-00716. Retrieved from https://rethinkthc.com/research/penner-2013-the-impact-of-marijuana
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.